Alice Parodi相关文献与解析，生知库 | 链接生命科学的每一步

Ciccarese, Giulia; Drago, Francesco; Broccolo, Francesco; Pastorino, Angela; Pizzatti, Laura; Atzori, Laura; Pilloni, Luca; Santinelli, Davide; Urbani, Alice; Parodi, Aurora; Tomasini, Carlo; Rongioletti, Franco

微生物学

黑色素瘤

肿瘤

肿瘤免疫

发表日期：2023

文献求助收藏

In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein

通过计算机模拟和体外实验评估三种基于 VX809 的混合衍生物作为 F508del CFTR 蛋白校正剂的作用机制

期刊:Pharmaceuticals

影响因子:

doi:10.3390/ph16121702

Debora Baroni, Naomi Scarano, Alessandra Ludovico, Chiara Brandas, Alice Parodi, Dario Lunaccio, Paola Fossa, Oscar Moran, Elena Cichero, Enrico Millo

CFTR

发表日期：2023

文献求助收藏

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays

基于 VX-809 的混合衍生物向类药物 F508del-CFTR 校正剂的演进：从分子建模到化学合成和生物测定

期刊:Pharmaceuticals

影响因子:

doi:10.3390/ph15030274

Alice Parodi, Giada Righetti, Emanuela Pesce, Annalisa Salis, Valeria Tomati, Cristina Pastorino, Bruno Tasso, Mirko Benvenuti, Gianluca Damonte, Nicoletta Pedemonte, Elena Cichero, Enrico Millo

CFTR

发表日期：2022

文献求助收藏

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis

NBD2 是噻唑基分子拯救突变型 F508del CFTR 所必需的：囊性纤维化多药疗法的 II 类校正剂

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom11101417

Chiara Brandas, Alessandra Ludovico, Alice Parodi, Oscar Moran, Enrico Millo, Elena Cichero, Debora Baroni

CFTR

发表日期：2021

文献求助收藏

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis

慢性肾脏病和代谢性酸中毒患者的肌肉蛋白质代谢胰岛素敏感性发生改变。

期刊:Kidney International

影响因子:12.6

doi:10.1038/ki.2015.247

Garibotto, Giacomo; Sofia, Antonella; Russo, Rodolfo; Paoletti, Ernesto; Bonanni, Alice; Parodi, Emanuele L; Viazzi, Francesca; Verzola, Daniela

Oncoviruses and melanomas: A retrospective study and literature review

致癌病毒与黑色素瘤：一项回顾性研究和文献综述

In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein

通过计算机模拟和体外实验评估三种基于 VX809 的混合衍生物作为 F508del CFTR 蛋白校正剂的作用机制

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays

基于 VX-809 的混合衍生物向类药物 F508del-CFTR 校正剂的演进：从分子建模到化学合成和生物测定

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis

NBD2 是噻唑基分子拯救突变型 F508del CFTR 所必需的：囊性纤维化多药疗法的 II 类校正剂

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis

慢性肾脏病和代谢性酸中毒患者的肌肉蛋白质代谢胰岛素敏感性发生改变。